The Prevalence of Marfan Syndrome in Korea
Shin Yi Jang1, Su Ra Seo2, Seung Woo Park1
1Division of Cardiology, Department of Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Abstract:
The aim of this study was to assess the prevalence of Marfan syndrome (MFS) in Korean adults. Data were collected from the National Health Insurance Service in Korea from 2006 through 2013. The data consisted of primary diagnoses related to MFS (Q87.4) diagnosed according to the 10th revision of the International Statistical Classification of Diseases and Related Health Problems. The age-standardized prevalence of MFS in adults was calculated using the estimated Korean population in 2010 as a reference. Overall, the prevalence of MFS was 0.90 per 100,000 persons in 2006 and 2.27 in 2013. For males in 2013, the prevalence per 100,000 persons was 2.61 in overall and 4.32 in 15-19 years-old. For females in 2013, the prevalence per 100,000 persons was 1.92 in overall and 3.02 in 10-14 years-old. In conclusion, currently, the age-standardized overall prevalence of MFS was 2.27 persons per 100,000 persons. And the overall age-standardized prevalence of MFS increased between 2006 and 2013 especially in 15-19 years-old males and 10-14 years-old females.
Insights
The prevalence of Marfan syndrome (MFS) in Korean adults increased from 0.90 to 2.27 per 100,000 people between 2006 and 2013. This rise was particularly notable in adolescent males and females.
Area of Science:
- Genetics and Hereditary Diseases
- Epidemiology
- Public Health
Background:
- Marfan syndrome (MFS) is a rare genetic disorder affecting connective tissue.
- Accurate prevalence data is crucial for understanding disease burden and healthcare needs.
- Previous MFS prevalence studies in Korea are limited, necessitating updated epidemiological assessment.
Purpose of the Study:
- To determine the age-standardized prevalence of Marfan syndrome (MFS) in the adult Korean population.
- To analyze trends in MFS prevalence from 2006 to 2013.
- To identify demographic variations in MFS prevalence within specific age and sex groups.
Main Methods:
- Utilized data from the Korean National Health Insurance Service (2006-2013).
- Identified MFS cases using the ICD-10 code Q87.4 for primary diagnoses.
- Calculated age-standardized prevalence rates based on the 2010 Korean population.
Main Results:
- The overall age-standardized prevalence of MFS in Korean adults was 0.90 per 100,000 in 2006, rising to 2.27 per 100,000 in 2013.
- In 2013, MFS prevalence was 2.61 per 100,000 overall for males and 4.32 per 100,000 for males aged 15-19.
- In 2013, MFS prevalence was 1.92 per 100,000 overall for females and 3.02 per 100,000 for females aged 10-14.
Conclusions:
- The age-standardized prevalence of Marfan syndrome in Korean adults significantly increased between 2006 and 2013.
- Adolescent males (15-19 years) and young females (10-14 years) showed a particularly pronounced increase in MFS prevalence.
- These findings highlight the need for continued surveillance and potentially targeted screening for MFS in the Korean population.
Related Concept Videos
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Aneurysm I: Introduction
Mitral Valve Prolapse I: Introduction
Mitral Stenosis I: Introduction
Mitral Stenosis II: Clinical features and Diagnostic Tests
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...


